All AbMole products are for research use only, cannot be used for human consumption.
Picrotoxinin, a potent convulsant, is a chloride channel blocker. Picrotoxinin is a noncompetitive GABAA receptor antagonist, which negatively modulates the action of GABA on GABAA receptors.
| Molecular Weight | 292.28 |
| Formula | C15H16O6 |
| CAS Number | 17617-45-7 |
| Solubility (25°C) | DMSO 90 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Richard W Olsen. GABA A receptor: Positive and negative allosteric modulators
[3] Guanghu Tong, et al. Revision of the Unstable Picrotoxinin Hydrolysis Product
[4] L A Porter. Picrotoxinin and related substances
[5] Steven W M Crossley, et al. Synthesis of (-)-Picrotoxinin by Late-Stage Strong Bond Activation
| Related Chloride Channel Products |
|---|
| Atractyloside potassium salt
Atractyloside potassium salt is a highly effective and specific inhibitor of mitochondrial ADP/ATP transport. Atractyloside potassium salt inhibited the chloride channel in rat heart mitochondrial membrane. Atractyloside potassium salt is a toxic diterpenoid glycoside, which can be isolated from the fruit of Atractyloside. |
| CaCCinh-A01
CaCCinh-A01 is a calcium-activated chloride channel (CaCC) inhibitor. |
| Eact
Eact is a activator of Ca 2+-activated Cl - channel transmembrane protein 16A (TMEM16A). |
| NPPB
NPPB is a blocker of the outwardly rectifying chloride channel (ORCC) with IC50 of 80 nM. NPPB has been shown to activate the GPR35-Gαi/o and GPR35-Gα16 pathways in HEK293 cells, inducing intracellular calcium mobilization. |
| T16Ainh-A01
T16Ainh-A01 is a Ca2+-activated Cl- channel transmembrane protein 16A (TMEM16A) inhibitor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
